From adhalinopathies to alpha-sarcoglycanopathies: an overview.
Jeanpierre
M
M
Hôpital Cochin et INSERM 129, CHU Cochin, Université Paris V, France.
Carrié
A
A
Piccolo
F
F
Leturcq
F
F
Azibi
K
K
De Toma
C
C
Beldjord
C
C
Merlini
L
L
Voit
T
T
Romero
N
N
Sunada
Y
Y
Tomé
F M
FM
Fardeau
M
M
Campbell
K P
KP
Kaplan
J C
JC
D002874:Chromosome Mapping; D003598:Cytoskeletal Proteins / Q000172:deficiency* / Q000235:genetics*; D049030:Dystroglycans; D005121:Extremities; D006801:Humans; D008562:Membrane Glycoproteins / Q000172:deficiency* / Q000235:genetics*; D018482:Muscle, Skeletal / Q000503:physiopathology; D009136:Muscular Dystrophies / Q000145:classification / Q000235:genetics / Q000378:metabolism*; D009154:Mutation; D010641:Phenotype; D049031:Sarcoglycans
D003598:Cytoskeletal Proteins; C483081:DAG1 protein, human; D008562:Membrane Glycoproteins; D049031:Sarcoglycans; D049030:Dystroglycans